Mass. big pharma not alone in layoffs, investors on sidelines as startups struggle
Though the late May layoff announcement from one of Massachusetts’ major biopharma companies dominated recent business headlines, experts point elsewhere for a true snapshot of what’s happening in the industry.Takeda Pharmaceuticals USA Inc. plans to lay off about 10% of its Massachusetts-based workforce — 641...